Sale!

Aphria Inc.: Q3 ’18

$17.00 $12.00

Included in this report:
• Welcome/Contact
• Cannin Tools
• Market & Industry Update
• Fundamental Analysis (Aphria Inc.)
• Branding
• Medical Research
• Cannabis Terminology
• Hemp Infographic
• Industry Terminology

About Aphria Inc.

Primary: Low-cost greenhouse production of high-quality medical cannabis in Canada. Ramping up for adult use market when legalized in Canada (October 2018), and planning significant exporting to global medical cannabis markets.
Secondary: support services including medical consultations, group therapies, and rehabilitation for veterans and first responders.

Last Updated 9/18/18

Category: